对穿孔性胃的治疗方法:随机对照试验的网络元分析
Elisabeth Wadewitz1, Juliane Friedrichs1, Maurizio Grilli2
1Department of Visceral, Vascular and Endocrine Surgery, University Hospital Halle (Saale), Martin Luther University Halle Wittenberg, Halle, Germany.
Langenbeck's archives of surgery
|September 5, 2025
概括
与开放式手术相比, laparoscopic手术显著降低了穿孔性胃的死亡率和并发症. 这项网络分析证实腹腔镜是PPU的黄金标准治疗方法.
科学领域:
- 胃肠病学和外科创新
- 比较有效性研究
- 基于证据的医学
背景情况:
- 穿孔性胃潰瘍 (PPU) 是具有重大病發率和死亡率的重大手術緊急情況.
- 对于PPU的最佳治疗策略仍然是正在进行的临床辩论和研究的主题.
- 评估不同手术方法的相对有效性对于改善患者的结果至关重要.
研究的目的:
- 进行网络元分析 (NMA),比较穿孔性胃潰瘍 (PPU) 的外科和替代治療方法.
- 评估不同治疗策略对PPU患者死亡率和其他关键临床结果的影响.
- 为管理PPU制定基于证据的建议.
主要方法:
- 在多个电子数据库 (PubMed,Embase,Cochrane图书馆等) 中进行系统搜索 对于相关的随机对照试验 (RCT).
- 网络元分析 (NMA) 框架遵循PRISMA指南,以综合包含的研究数据.
- 使用标准化平均差异 (SMD) 分析连续数据和二进制数据的几率比率 (OR),以95%的置信区间 (CI).
主要成果:
- 在NMA中包括了16项涉及1259名患者的研究.
- 与开放性手术相比, laparoscopic 手术的死亡率显著降低 (OR 0. 36, 95% CI 0. 17- 0. 75).
- laparoscopic 方法也显示了术后并发症的显著减少,包括伤口感染 (OR 0.15,95% CI 0.08- 0.27) 和骨髓 (OR 0.33,95% CI 0.18- 0.59).
结论:
- 网络分析提供了强有力的证据,支持腹腔镜手术优于PPU的开放手术.
- 根据死亡率和并发症的减少, laparoscopic 手术已被确认为穿孔性胃潰瘍的黄金标准治疗方法.
- 目前对PPU的替代治疗方法的证据不足以得出最终的结论.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
144
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
144
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
403
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
403
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
01:28Peptic Ulcer Disease II: Pathophysiology
821
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
821
01:30Peptic Ulcer Disease I: Introduction
282
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
282